Venus Remedies Ltd. benchmarking: Perfomance to industry peers

Financial

	Venus Remedies	Lincoln Pharma	Kwality Pharma
Operational Metrics
Financials
5 yr Average ROE	8.87 %	15.1 %	25.27 %
5yr average Equity Multiplier	1.32	1.26	1.96
5yr Average Asset Turnover Ratio	0.96	0.82	1.05
5yr Avg Net Profit Margin	6.91 %	14.59 %	11.66 %
Price to Book	1.68	1.38	3.2
P/E	14.16	12.34	18.94
5yr Avg Cash Conversion Cycle	46.96 Days	-6.41 Days	55.02 Days
Inventory Days	75.64 Days	43.91 Days	67.04 Days
Days Receivable	54.28 Days	91.75 Days	132.46 Days
Days Payable	58.86 Days	128.38 Days	126.93 Days
5yr Average Interest Coverage Ratio	396.11	63.13	16.13
5yr Avg ROCE	8.42 %	19.81 %	34.73 %
5yr Avg Operating Profit Margin	10.14 %	18.35 %	23.23 %
5 yr average Debt to Equity	0.08	0.0	0.46
5yr CAGR Net Profit	-6.01 %	5.76 %	21.34 %
5yr Average Return on Assets	6.69 %	11.92 %	12.96 %
Shareholdings
Promoter Holding	41.76 %	49.78 %	54.83 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	5.7 %	0.38 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Venus Remedies	Lincoln Pharma	Kwality Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Central Nervous System 0 Cardiovascular System 0 Blood and Blood Forming Organs 0 Parasitology 0 Musculo-Skeletal System 0 Genito Urinary System and Sex Hormones 0 Alimentary Tract and Metabolism 0 Respiratory Systems 0 General Anti Infectives 0	Product Wise Break-Up Genito Urinary System and Sex Hormones 1.3 Blood and Blood Forming Organs 0.3 Parasitology 9.7 Central Nervous System (CNS) 0.4 Pharmaceuticals 0 Cardiac Science 4.3 Musculo-Skeletal System 16.7 Alimentary Tract and Metabolism 6.3 Anti-Infective 26.3 Respiratory Systems 8.3 Others 26.4	-
Location Wise Break-Up	Location Wise Break-Up India 33.0 Rest of the World 0 Others 67.0	Location Wise Break-Up India 31.4 Rest of the World 68.6	Location Wise Break-Up India 47.21 Rest of the World 0 Others 52.79